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Introduction
Increasingly, abnormal metabolic substrate utilisation is
considered a cause of heart failure (HF). Hyperpolarised
13C MR, a technique in which the fate of
13C-labelled
metabolites can be followed in vivo using MR imaging
or spectroscopy, has enabled non-invasive assessment of
cardiac substrate utilisation.
Purpose
The aim of this study was to monitor carbohydrate
metabolism alongside cardiac structure and function,
throughout HF progression.
Methods
Dilated cardiomyopathy (DCM) was induced in pigs (n =
4) by rapid ventricular pacing at 188 bpm for 4-5 weeks.
Pigs were examined at baseline and at weekly time points
throughout DCM progression. At each time point, cine
MRI was used to assess cardiac structure and function,
0.05 mmol/kg hyperpolarised
13C2-pyruvate was adminis-
tered intravenously and MRS was used to assess Krebs
cycle-mediated
13C-glutamate production, and hyperpo-
larised
13C1-pyruvate was administered to assess H
13CO3
-
production from pyruvate dehydrogenase (PDH), and
thus relative carbohydrate oxidation. A new cardiac and
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Figure 1 A) Representative short-axis
13C images of the healthy pig heart, acquired with a surface coil. B) Comparison of parameters of structural
and metabolic remodeling in the pig heart throughout the progression of DCM. *p<0.05.
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13C MRI sequence was used to image
13C1-pyruvate and H
13CO3
-. The chemical shift-specific
pulse sequence used allowed temporally resolved imaging
of
13C1-pyruvate and H
13CO3
- with 9 mm in-plane spatial
resolution in multiple slices (two in these studies), all
within a 23 s scan. Pigs were sacrificed after presentation
of clinical symptoms or >25% increase in end diastolic
volume (EDV).
Results
At baseline, pigs had an EDV of 62 ± 5 ml. The maxi-
mum
13C-glutamate/
13C2-pyruvate ratio was 4.9 ± 1.2%
(Fig 1A), whereas the mean H
13CO3
-/
13C1-pyruvate ratio
across the anterior myocardium was 2.0 ± 0.3% (Fig 1B).
After 1 week of pacing, the
13C-glutamate/
13C2-pyruvate
decreased significantly to 2.1 ± 0.8%, and was main-
tained at this level throughout DCM development. EDV
increased linearly with pacing duration, and after 2-3
weeks of pacing was significantly elevated to 84 ± 12 ml.
After 4-5 weeks of pacing (at the final time point), the
ejection fraction (EF) was decreased by 40% compared
with the baseline value, and the H
13CO3
-/
13C1-pyruvate
was decreased to 0.8±0.2%.
Conclusions
In conclusion, metabolism of
13C2-pyruvate to
13C-
glutamate was reduced by 59% at an early stage in
DCM, with no change to PDH flux. Reduced
13C-gluta-
mate relative to H
13CO3
- production could be an early
marker of disease. Carbohydrate oxidation via PDH
was maintained until end-stage DCM, at which point
PDH flux was reduced by 62%. With further develop-
ment, metabolic imaging using hyperpolarised
13CM R
may similarly characterize HF progression in patients.
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